1. Genetic tests
  2. Dihydropyrimidine dehydrogenase deficiency/5-fluorouracil toxicity - Pharmacogenetics (4 variants: DPYD*2A, DPYD*13, c.2846A>T, HapB3)

Dihydropyrimidine dehydrogenase deficiency/5-fluorouracil toxicity - Pharmacogenetics (4 variants: DPYD*2A, DPYD*13, c.2846A>T, HapB3)

Genetic test Export to PDF
Full name:
Dihydropyrimidine dehydrogenase deficiency/5-fluorouracil toxicity - Pharmacogenetics (4 variants: DPYD*2A, DPYD*13, c.2846A>T, HapB3)
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Drug Response
Specimen:
Peripheral (whole) blood on EDTA,
DNA
Method category:
Targeted variant analysis
Method technique:
Bi-directional Sanger Sequence analysis
Laboratory:
Centrum Medische Genetica - UZ Antwerpen
RIZIV code:
565390-565401
Accreditation (ISO 15189):
2023-11-09 / 2024-05-08
Turnaround time (maximum):
2 weeks
Created:
14 Dec 2022 - 11:53
Changed:
22 Jan 2024 - 13:45